Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Nasopharynx

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cancer of Nasopharynx in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiou, SH; Chow, KC; Tsai, MH1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cancer of Nasopharynx

ArticleYear
Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells.
    International journal of oncology, 2001, Volume: 19, Issue:5

    Topics: Adult; Animals; Blotting, Western; Butyrates; Cells, Cultured; Chloramphenicol O-Acetyltransferase; DNA Primers; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; In Situ Hybridization; Male; Mice; Mice, SCID; Middle Aged; Nasopharyngeal Neoplasms; Platelet Activating Factor; Prognosis; Receptors, Interleukin-2; Reverse Transcriptase Polymerase Chain Reaction; Transfection; Tumor Cells, Cultured

2001